Sex Differences in the Risk of Bladder Cancer among Kidney Transplant Recipients and Patients with Kidney Failure Receiving Hemodialysis: A Nationwide Cohort Study
American Journal of Nephrology · 2025
DOI: 10.1159/000543298 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift American Journal of Nephrology, 2025. Verfasst von Hoon Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, Gangneung Asan Hospital, College of Medicine, University of Ulsan, Gangneung, Republic of Ko…. Hauptthemen laut MEDLINE: Kidney Transplantation, Urinary Bladder Neoplasms, Renal Dialysis, Kidney Failure, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Introduction
Although both patients with kidney failure (KF) receiving hemodialysis (HD) and kidney transplantation (KT) recipients (KTRs) have a high risk of bladder cancer, how this risk changes in the transition from dialysis to KT is unknown. In this study, we aimed to investigate the risk of bladder cancer in KTRs and patients on HD.
Methods
This was a nationwide longitudinal cohort study of 66,547 participants from the National Health Insurance Service cohort who started HD for patients with KF or who received KT from 2002 to 2020. The primary outcome was the diagnosis of bladder cancer, which was defined as the composite of diagnostic codes and either hospitalization or ≥2 outpatient visits for bladder cancer.
Results
During mean follow-ups of 4.2 and 7.9 years in the HD and KT groups, respectively, the incidence rates of bladder cancer were 1.1/1,000 and 0.3/1,000 person-years, respectively. In the time-dependent multivariable Cox models, compared to patients on HD, the adjusted hazard ratio (aHR) for bladder cancer among KTRs was 0.36 (95% confidence interval [CI], 0.21–0.60; p < 0.001). Among men, this aHR was 0.29 (95% CI, 0.15–0.55; p < 0.001); however, no statistically significant association between the kidney replacement therapy modality and the risk of bladder cancer was observed among women. Landmark analysis performed to avoid immortal time bias by redefining time zero as a specific landmark time (2 and 5 years after HD initiation or KT) revealed similar results.
Conclusion
The risk of bladder cancer was significantly lower among KTRs than that among patients receiving HD, particularly among men.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nephrology, Department of Internal Medicine, Gangneung Asan Hospital, College of Medicine, University of Ulsan, Gangneung, Republic of Korea.
- Department of Urology, Gangneung Asan Hospital, College of Medicine, University of Ulsan, Gangneung, Republic of Korea.
- Department of Data Science, Hanmi Pharm. Co., Ltd, Seoul, Republic of Korea.
- Division of Nephrology, Department of Internal Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea.
Zitieren
APA
Yu, H., Kim, S. J., Bae, Y., Kim, M., & Jung, C. Y. (2025). Sex Differences in the Risk of Bladder Cancer among Kidney Transplant Recipients and Patients with Kidney Failure Receiving Hemodialysis: A Nationwide Cohort Study. American Journal of Nephrology. https://doi.org/10.1159/000543298
Vancouver
Yu H, Kim SJ, Bae Y, Kim M, Jung CY. Sex Differences in the Risk of Bladder Cancer among Kidney Transplant Recipients and Patients with Kidney Failure Receiving Hemodialysis: A Nationwide Cohort Study. American Journal of Nephrology. 2025. doi:10.1159/000543298
BibTeX
@article{Yu2025,
author = {Yu, Hoon and Kim, Sung Jin and Bae, Yoonjong and Kim, Mina and Jung, Chan-Young},
title = {Sex Differences in the Risk of Bladder Cancer among Kidney Transplant Recipients and Patients with Kidney Failure Receiving Hemodialysis: A Nationwide Cohort Study},
journal = {American Journal of Nephrology},
year = {2025},
doi = {10.1159/000543298}
}
EUVIMED